Europe Diabetes Care Devices Market By Product Type (Blood Glucose Monitoring Devices {Continuous Glucose Monitoring Systems and Self-Monitoring Blood Glucose Systems} and Treatment Devices {Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, and Others}), By Technology (Wearable Devices and Non-Wearable Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Home Care), Regional Market Size, Segmental analysis, Country Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Blood Glucose Monitoring Devices        
  • Continuous Glucose Monitoring Systems 
  • Self-Monitoring Blood Glucose Systems 
• Treatment Devices
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • Insulin Syringes
  • Others

By Technology

• Wearable Devices
• Non-Wearable Devices

By Distribution Channel

•  Hospital Pharmacies
• Retail Pharmacies
• Online Stores

By End-User

• Hospitals and Clinics 
• Ambulatory Surgical Centers
• Home Care

By Region

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Switzerland
• Netherlands
• Belgium
• Sweden
• Poland
• Portugal
• Greece
• Czech Republic
• Hungary
• Finland
• Rest of Europe

List of Companies:

• Ypsomed
• GlucoMen
• Owen Mumford
• Boehringer Ingelheim
• Novartis
• Lifescan
• F. Hoffmann-La Roche AG
• Diasend
• Nemaura Medical
• DarioHealth
• iHealth Lab
• GlucoRx
• MediWise
• Hapilabs
• Biosense Technologies